Galmed Pharmaceuticals Statistics
Total Valuation
GLMD has a market cap or net worth of $8.66 million. The enterprise value is -$11.93 million.
Market Cap | 8.66M |
Enterprise Value | -11.93M |
Important Dates
The next estimated earnings date is Thursday, November 13, 2025, after market close.
Earnings Date | Nov 13, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
GLMD has 5.48 million shares outstanding. The number of shares has increased by 323.44% in one year.
Current Share Class | 5.48M |
Shares Outstanding | 5.48M |
Shares Change (YoY) | +323.44% |
Shares Change (QoQ) | +121.85% |
Owned by Insiders (%) | 1.19% |
Owned by Institutions (%) | 4.58% |
Float | 5.40M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 0.42 |
P/TBV Ratio | 0.42 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 8.71
Current Ratio | 8.71 |
Quick Ratio | 8.66 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -11.52 |
Financial Efficiency
Return on equity (ROE) is -53.99% and return on invested capital (ROIC) is -27.19%.
Return on Equity (ROE) | -53.99% |
Return on Assets (ROA) | -24.21% |
Return on Invested Capital (ROIC) | -27.19% |
Return on Capital Employed (ROCE) | -34.24% |
Revenue Per Employee | n/a |
Profits Per Employee | -$1.45M |
Employee Count | 6 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -62.38% in the last 52 weeks. The beta is 0.50, so GLMD's price volatility has been lower than the market average.
Beta (5Y) | 0.50 |
52-Week Price Change | -62.38% |
50-Day Moving Average | 1.47 |
200-Day Moving Average | 1.89 |
Relative Strength Index (RSI) | 58.88 |
Average Volume (20 Days) | 79,050 |
Short Selling Information
Short Interest | 98,393 |
Short Previous Month | 161,904 |
Short % of Shares Out | 1.82% |
Short % of Float | n/a |
Short Ratio (days to cover) | 0.45 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -7.03M |
Pretax Income | -8.72M |
Net Income | -8.72M |
EBITDA | -6.99M |
EBIT | -7.03M |
Earnings Per Share (EPS) | -$4.27 |
Balance Sheet
The company has $20.53 million in cash and n/a in debt, giving a net cash position of $20.53 million or $3.75 per share.
Cash & Cash Equivalents | 20.53M |
Total Debt | n/a |
Net Cash | 20.53M |
Net Cash Per Share | $3.75 |
Equity (Book Value) | 20.52M |
Book Value Per Share | 3.87 |
Working Capital | 18.66M |
Cash Flow
Operating Cash Flow | -5.47M |
Capital Expenditures | n/a |
Free Cash Flow | -5.47M |
FCF Per Share | -$1.00 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
GLMD does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -323.44% |
Shareholder Yield | -323.44% |
Earnings Yield | -101.47% |
FCF Yield | -63.61% |
Analyst Forecast
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | Hold |
Analyst Count | 1 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
The last stock split was on August 30, 2024. It was a reverse split with a ratio of 1:12.
Last Split Date | Aug 30, 2024 |
Split Type | Reverse |
Split Ratio | 1:12 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 2 |